Published in Clin Exp Immunol on July 01, 1987
Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential. Blood (2007) 1.25
Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev (2003) 1.02
Segregation analysis in Shwachman-Diamond syndrome: evidence for recessive inheritance. Am J Hum Genet (2000) 0.80
Phagocyte function in juvenile periodontitis. Infect Immun (1990) 0.80
Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis. Ann Rheum Dis (1990) 0.75
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med (1973) 14.88
THE SYNDROME OF PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION. J Pediatr (1964) 4.12
Oxidants from phagocytes: agents of defense and destruction. Blood (1984) 3.20
Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol (1982) 3.11
Shwachman's syndrome. A review of 21 cases. Arch Dis Child (1980) 2.32
Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10
Mediators of immunity: lymphokines and monokines. Adv Immunol (1980) 1.99
An inherited defect of neutrophil mobility in Shwachman syndrome. J Pediatr (1979) 1.42
Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes. Clin Exp Immunol (1986) 1.40
Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. Infect Immun (1979) 1.27
Co-oxidation of luminol by hypochlorite and hydrogen peroxide implications for neutrophil chemiluminescence. Biochem Biophys Res Commun (1985) 1.19
Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line. J Invest Dermatol (1983) 1.12
Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera. Arthritis Rheum (1982) 1.12
Microtubule dynamics and glutathione metabolism in phagocytizing human polymorphonuclear leukocytes. J Cell Biol (1978) 1.11
Mechanisms of regulating the respiratory burst in leukocytes. Contemp Top Immunobiol (1984) 1.03
Tubulin tyrosinolation in human polymorphonuclear leukocytes: studies in normal subjects and in patients with the Chediak-Higashi syndrome. J Cell Biol (1982) 0.94
Characterisation of the under-agarose method for quantifying migration of highly purified human monocytes. J Immunol Methods (1984) 0.92
Frequent myocardial lesions in Shwachman's syndrome. Eight fatal cases among 16 Finnish patients. Acta Paediatr Scand (1984) 0.92
Regulation of human leukocyte function by lipoxygenase products of arachidonic acid. Contemp Top Immunobiol (1984) 0.89
Granulocyte chemiluminescence in adolescent patients with cystic fibrosis. Am Rev Respir Dis (1982) 0.85
Constant defect in neutrophil locomotion but with age decreasing susceptibility to infection in Shwachman syndrome. Clin Exp Immunol (1984) 0.84
Correction of defective chemotaxis with thiamine in Shwachman-Diamond syndrome. Lancet (1984) 0.81
Antimalarial effects of riboflavin deficiency. Lancet (1985) 0.80
Effect of interleukin 1 on chemotaxis and chemiluminescence of human neutrophils. Tohoku J Exp Med (1986) 0.80
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (1999) 4.98
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology (1998) 3.22
IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease. Lancet (1983) 3.17
Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ (2001) 2.91
A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med (1992) 2.86
Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet (1991) 2.76
Immunoglobulin-containing cells in the intestinal mucosa and immunoglobulins in the intestinal juice in children. Clin Exp Immunol (1972) 2.34
Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia. Gut (2003) 2.33
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis (2009) 2.22
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum (1991) 2.10
Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis (1998) 2.09
Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol (2012) 2.03
Malabsorption syndrome with cow's milk intolerance. Clinical findings and course in 54 cases. Arch Dis Child (1975) 2.00
Response of the jejunal mucosa to cow's milk in the malabsorption syndrome with cow's milk intolerance. A light- and electron-microscopic study. Acta Paediatr Scand (1973) 1.98
A genetic test which can be used to diagnose adult-type hypolactasia in children. Gut (2004) 1.95
Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res (2002) 1.92
Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis (1992) 1.86
Increase in gamma/delta T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease. Gut (1991) 1.80
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis (2004) 1.76
Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy (2005) 1.75
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Aliment Pharmacol Ther (2008) 1.72
Gastrointestinal complaints and diagnosis in children: a population-based study. Acta Paediatr (2004) 1.66
IgA deficiency in children. Immunoglobulin-containing cells in the intestinal mucosa, immunoglobulins in secretions and serum IgA levels. Clin Exp Immunol (1973) 1.66
Reticulin antibody in children with malabsorption. Lancet (1972) 1.64
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis (2004) 1.58
Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis (2005) 1.54
Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity. Rheumatol Int (2001) 1.53
Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy. Clin Exp Rheumatol (1994) 1.52
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
Cow's milk allergy as a predictor of bronchial hyperresponsiveness and airway inflammation at school age. Clin Exp Allergy (2010) 1.50
Intestinal immunoglobulins in children with coeliac disease. Gut (1972) 1.49
An increased level of antibodies to beta-lactoglobulin is a risk determinant for early-onset type 1 (insulin-dependent) diabetes mellitus independent of islet cell antibodies and early introduction of cow's milk. Diabetologia (1992) 1.48
Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet (1992) 1.45
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
Juvenile chronic arthritis in adult life: a study of long-term outcome in patients with juvenile chronic arthritis or adult rheumatoid arthritis. Clin Rheumatol (1999) 1.43
Prolonged exclusive breast feeding and heredity as determinants in infantile atopy. Arch Dis Child (1987) 1.42
Immunochemical study of the malabsorption syndrome with cow's milk intolerance. Gut (1973) 1.41
A model for the involvement of MHC class II proteins in the development of type 1 (insulin-dependent) diabetes mellitus in response to bovine serum albumin peptides. Diabetologia (1993) 1.39
Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38
Absence of IgA and growth hormone deficiency associated with short arm deletion of chromosome 18. Arch Dis Child (1973) 1.38
Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun (1998) 1.36
Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet (1993) 1.34
Clinical findings and intestinal immunoglobulins in children with partial IgA deficiency. Acta Paediatr Scand (1979) 1.32
Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis (2002) 1.32
Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation. J Pediatr (1979) 1.31
Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: A prospective study of 6209 infants. J Allergy Clin Immunol (1999) 1.28
Morphometric study of the jejunal mucosa in various childhood enteropathies with special reference to intraepithelial lymphocytes. J Pediatr Gastroenterol Nutr (1982) 1.27
Celiac disease in insulin-dependent diabetes mellitus. J Pediatr (1986) 1.24
Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity. Scand J Rheumatol (2004) 1.21
Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes. Clin Exp Immunol (2008) 1.20
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol (2011) 1.19
Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19
IgA deficiency in children. A clinical study with special reference to intestinal findings. Arch Dis Child (1971) 1.19
Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun (2005) 1.19
Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology (1996) 1.19
Reactive arthritis. Clin Rheum Dis (1985) 1.18
Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum (1988) 1.18
Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum (1996) 1.17
Chronic non-specific diarrhoea. Arch Dis Child (1985) 1.17
Clinical, radiographic and MRI findings of the temporomandibular joint in patients with different rheumatic diseases. Int J Oral Maxillofac Surg (2006) 1.17
Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol (1988) 1.16
Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis (2002) 1.14
Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group. Diabet Med (1996) 1.14
Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog (1990) 1.13
Haplotype analysis to determine the position of a mutation among closely linked DNA markers. Hum Mol Genet (1993) 1.11
Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol (1998) 1.11
The T/G 13915 variant upstream of the lactase gene (LCT) is the founder allele of lactase persistence in an urban Saudi population. J Med Genet (2007) 1.11
Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy (2008) 1.10
T-cell reactivity to wheat gluten in patients with insulin-dependent diabetes mellitus. Scand J Immunol (1998) 1.10
Congenital lactase deficiency. A clinical study on 16 patients. Arch Dis Child (1983) 1.10
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia (2010) 1.10
Time of appearance of immunoglobulin-containing cells in the mucosa of the neonatal intestine. Pediatr Res (1980) 1.10
Transcriptional downregulation of the lactase (LCT) gene during childhood. Gut (2005) 1.09
Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum (2000) 1.09
Frequency and nature of relapses in children suffering from the malabsorption syndrome with gluten intolerance. Acta Paediatr Scand (1970) 1.09
Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. Eur J Pediatr (1998) 1.09
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis (2009) 1.09
Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheum Dis (2005) 1.09
Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin. Diabetes (1997) 1.08
Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) (1999) 1.08
Progression of cervical spine changes in patients with early rheumatoid arthritis. J Rheumatol (1997) 1.08
Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis (2004) 1.07
Late mucosal relapse in a boy with coeliac disease and cow's milk allergy. Acta Paediatr Scand (1986) 1.07
Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Dis (2001) 1.07
Immunoglobulin E specific to wheat and rye flour proteins. Clin Allergy (1977) 1.06
Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up study. Br Med J (Clin Res Ed) (1988) 1.06
Cell-mediated immune response in the diseased joints in patients with reactive arthritis. Scand J Immunol (1986) 1.06
[Antibiotic treatment in rheumatoid arthritis?]. Duodecim (1995) 1.06
Assignment of the locus for congenital lactase deficiency to 2q21, in the vicinity of but separate from the lactase-phlorizin hydrolase gene. Am J Hum Genet (1998) 1.04
Infantile colic and feeding. Arch Dis Child (1986) 1.02
Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum (1991) 1.02
Development of immune response to cow's milk proteins in infants receiving cow's milk or hydrolyzed formula. J Allergy Clin Immunol (1995) 1.02
Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. Vaccine (1999) 1.02